SCM
BIIB icon

Sterling Capital Management’s Biogen BIIB Stock Holding History

Sterling Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$942K Sell
5,136
-3,525
-41% -$650K 0.02% 525
2025
Q4 		$1.52M Sell
8,661
-371
-4% -$60.6K 0.02% 492
2025
Q3 		$1.27M Sell
9,032
-691
-7% -$93.4K 0.02% 560
2025
Q2 		$1.22M Buy
9,723
+1,622
+20% +$202K 0.02% 557
2025
Q1 		$1.11M Sell
8,101
-535
-6% -$76.5K 0.02% 581
2024
Q4 		$1.32M Buy
8,636
+3,071
+55% +$518K 0.02% 553
2024
Q3 		$1.08M Buy
+5,565
New +$1.16M 0.01% 571
2019
Q3 		$3.53M Sell
15,166
-20,800
-58% -$4.84M 0.03% 295
2019
Q2 		$8.41M Buy
35,966
+11,763
+49% +$2.72M 0.08% 197
2019
Q1 		$5.72M Sell
24,203
-685
-3% -$216K 0.06% 230
2018
Q4 		$7.49M Buy
24,888
+180
+0.7% +$57.4K 0.08% 196
2018
Q3 		$8.73M Buy
+24,708
New +$8.51M 0.08% 206
2018
Q2 		– Sell
-28,718
Closed -$7.86M – 845
2018
Q1 		$7.86M Buy
28,718
+3,330
+13% +$1.03M 0.07% 211
2017
Q4 		$8.09M Buy
25,388
+15,560
+158% +$4.99M 0.07% 214
2017
Q3 		$3.08M Buy
9,828
+8,707
+777% +$2.58M 0.03% 307
2017
Q2 		$304K Sell
1,121
-26,196
-96% -$6.93M ﹤0.01% 833
2017
Q1 		$7.47M Buy
+27,317
New +$7.72M 0.07% 210
2015
Q3 		– Sell
-530
Closed -$214K – 969
2015
Q2 		$214K Buy
+530
New +$213K ﹤0.01% 846
2014
Q3 		– Sell
-1,403
Closed -$442K – 893
2014
Q2 		$442K Buy
+1,403
New +$422K ﹤0.01% 753
2014
Q1 		– Sell
-840
Closed -$235K – 937
2013
Q4 		$235K Sell
840
-14,746
-95% -$3.81M ﹤0.01% 755
2013
Q3 		$3.75M Buy
+15,586
New +$3.49M 0.04% 165

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sterling Capital Management's BIIB Position: Q1 2026 in Review

Sterling Capital Management reduced its Biogen (BIIB) stake by 41% in Q1 2026, selling an estimated $650K and leaving 5,136 shares worth $942K. The position accounts for 0.02% of the portfolio, ranked #525.

Sterling Capital Management first reported a position in BIIB in Q3 2013 and has held it in 21 quarters since. The position peaked at $8.73M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Sterling Capital Management held 5,136 shares of Biogen worth $942K as of Q1 2026.
  • Sterling Capital Management sold 3,525 Biogen shares in Q1 2026, an estimated $650K.
  • Biogen made up 0.02% of Sterling Capital Management's portfolio in Q1 2026, its #525 holding.
  • Sterling Capital Management first reported a position in Biogen in Q3 2013 and has held it in 21 quarters since.
  • Sterling Capital Management's Biogen position peaked at $8.73M in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.